Myeloproliferative Disorders Foundation Donate to the Myeloproliferative Disorders Foundation
   
New MPD Foundation Navigation

Search MPD Foundation:

Register for a FREE MPD Foundation Newsletter!

 

MPD Foundation Grant Recipients

Since 2000, the MPD Foundation has awarded grants to worthy MPD researchers on a quest to advance the science of MPDs in the field of drug development, epidemiology and general research. 

Click here for a list of selected abstracts from MPD Foundation funded grants

2009-2010

MPD Research Alliance:

Gary Gilliland, MD, PhD
Harvard Medical School
"Genetics and Therapy of Myeloproliferative Disorders"

Ronald Hoffman, MD
Mt. Sinai School of Medicine
"Use of Stem Cells Derived from the Philadelphia Chromosome Negative Myeloproliferative Disorders as a Chemotherapeutic Target"

Josef Prchal, MD
University of Utah
Define somatic mutations that precede JAK2 mutation in PV patients & monitor their changes in response to Pegasys"

Ayalew Tefferi, MD
Mayo Clinic
"Continued Development of Clinical Database-Linked Cell and Serum Bank of Patients with Myeloproliferative Disorders"

Return to top of page

New Investigator:

Benjamin Braun, MD, PhD
University of California, San Francisco
"Oncogenic Ras in Leukemia Stem Cells"

Francois Delhommeau, PhD, PharmD
Saint-Antoine Hospital, Paris
"Characterization and Function of a New Tumor Suppressor Gene in Myeloproliferative Disorders"

Robert Kralovics, PhD
Austrian Academy of Sciences, Vienna
"Genomic approaches for disease gene identification in myeloproliferative neoplasms"

Dorothy Sipkins, MD, PhD
University of Chicago
"In Vivo Imaging of PV and CIMF CD34+ Progenitor Cell Interactions with Bone Marrow Microenvironment"

2006-2008

Gary Gilliland, PhD, MD
Harvard Medical School

MPD Research Alliance

Ayalew Tefferi, MD
Mayo Clinic, Rochester

MPD Research Alliance

Ronald Hoffman, PhD
Mt. Sinai School of Medicine (2007-Present)
University of Illinois, Chicago (2006-2007)

MPD Research Alliance

Gail Roboz, MD

Weill Cornell Medical College

"Arsenic trioxide (ATO) combined with cytosine arabinoside (ara-c) for the treatment of advanced myelofibrosis and myelofibrosis transformed to acute myeloid leukemia"

2005

Xiaomei Ma, PhD
Yale University School of Medicine
"Epidemiology of Chronic Myeloproliferative Disorders Grant"

2004

Alison Moliterno, MD
Johns Hopkins
"Proteomic Approach to the Diagnosis of Chronic MPD's.

Mingjiang Xu, MD, Ph.D.
University of Illinois, at Chicago
"Exploration of a unique phosphatase as a potential therapeutic target for treatment of PV"

Ron Hoffman, MD
University of Illinois at Chicago
"Continuation of 2003 grant. "

Jose Lopez, MD
Baylor College of Medicine
"Macrophage-derived Prothrombotic Microparticles and Thrombosis in Myeloproliferative Disorders"

2003

Xiao-Feng Yang, MD, PhD
Baylor College of Medicine
"Novel Antigen targets for Immunotherapy in the Myeloproliferative Diseases"

Ruben Mesa, MD
Mayo Clinic, Rochester, NY
"Novel therapies for Myelofibrosis with Myeloid Metaplasia"

Richard D'Andrea, MD
Child Health Research Institute, Australia
"Identification of Growth Factor Receptor Mutations in Polycythemia Vera"

Ron Hoffman, MD
University of Illinois at Chicago
"Organizational grant for International MPD Research Consortium in application for $25 million grant from NCI"

Vahid Afshar-Kharghan, MD
Baylor College of Medicine
"Continuation of 2002 Grant"

2002

Vahid Afshar-Kharghan
MD Baylor College of Medicine
"Genetic factors that influence platelet function in PV and ET, and their effect on the frequency of thrombotic complications."

Dr. Josef Prchal
Baylor College of Medicine
"Continuation of 2001 Grant"

Dr. Josef Prchal
Baylor College of Medicine
"Continuation of 2000 Grant"

2001

Dr. Josef Prchal
Baylor College of Medicine
"Locate and identify the gene or genes whose defects are responsible for ET."

Dr. Josef Prchal
Baylor College of Medicine
"Continuation of 2000 Grant"

2000

Dr. Josef Prchal
Baylor College of Medicine
"Locate and identify the gene or genes that lead to the development of the Polycythemia Vera phenotype."

Return to top of page